Latest News

Deutsche Lufthansa has recently faced sharp trading swings as investors reacted to concerns about margin pressure, elevated leverage, and sector weakness ahead of its 6 March 2026 earnings announcement. This volatility underlines how closely the market is watching Lufthansa’s ability to manage costs and restore profitability amid a still-challenging aviation backdrop. Against this backdrop of heightened earnings uncertainty, we’ll examine how margin pressure risk could reshape Lufthansa’s...

Vericel (VCEL) has wrapped up FY 2025 with fourth quarter revenue of US$92.9 million and basic EPS of US$0.46, supported by trailing twelve month revenue of US$276.3 million and EPS of US$0.33. The company has seen revenue move from US$237.2 million to US$276.3 million on a trailing basis, while EPS over the same window shifted from US$0.21 to US$0.33. This sets up a story that links growing earnings with improving net profit margins. With trailing net profit margins cited at 6% versus 4.4% a...

FTAI Aviation (FTAI) closed out FY 2025 with Q4 revenue of US$662.0 million and basic EPS of US$1.09, while trailing twelve month revenue reached about US$2.5 billion with EPS of US$4.66, underscoring a full year firmly in profitable territory. The company has seen quarterly revenue move from US$498.8 million and EPS of US$0.85 in Q4 2024 to US$662.0 million and US$1.09 respectively in Q4 2025, alongside trailing twelve month net income rising from a loss of US$32.1 million in Q4 2024 to a...

Aclaris Therapeutics FY 2025 results in focus Aclaris Therapeutics (ACRS) just closed out FY 2025 with Q4 total revenue of US$1.3 million, basic EPS of a US$0.16 loss, and net income loss excluding extra items of US$19.8 million, setting a clear tone for how the year wrapped up. The company has seen quarterly revenue move from US$9.2 million in Q4 2024 to US$1.3 million in Q4 2025, while basic EPS shifted from a US$1.01 loss to a US$0.16 loss over the same period. This gives investors a...

Globant released its quarterly earnings on 26 February 2026, with analysts having expected earnings per share of US$1.40 and investors closely watching for revenue trends and management guidance. This earnings event has become a focal point for understanding whether Globant’s recent revenue momentum can translate into sustained profitability and clearer visibility on future performance. We’ll now examine how anticipation around Globant’s US$1.40 expected EPS and management commentary could...

NovoCure (NVCR) closed out FY 2025 with Q4 revenue of US$174.4 million and a basic EPS loss of US$0.22, setting the tone for a year where both top line and per share results remained in focus for investors. Over the past six quarters, revenue has moved from US$155.1 million in Q3 2024 to US$174.4 million in Q4 2025, while quarterly basic EPS ranged from a loss of US$0.61 in Q4 2024 to a loss of US$0.22 in Q4 2025. This leaves the story centered on how much growth can offset ongoing pressure...

J. M. Smucker (SJM) has just posted Q3 2026 results with revenue of US$2.3 billion and a basic EPS loss of US$6.79, as net income excluding extra items came in at a loss of US$724.2 million. Over recent quarters the company has seen revenue move from US$2.1 billion in Q2 2025 to US$2.3 billion in Q3 2026, while basic EPS has swung between a loss of US$6.85 in Q4 2025 and a profit of US$2.26 in Q2 2026 before returning to a loss in the latest period. This sets up a results season in which...

Nordson (NDSN) just posted first quarter earnings with sales of US$669.46 million and net income of US$133.38 million, and management raised both full year 2026 and second quarter sales guidance. See our latest analysis for Nordson. At a share price of US$292.62, Nordson has delivered a 23.13% 90 day share price return and a 41.72% 1 year total shareholder return. This suggests momentum has been building around the recent earnings beat, raised 2026 guidance and a series of upbeat analyst...

Perrigo FY 2025 headline results Perrigo (PRGO) has wrapped up FY 2025 with fourth quarter revenue of US$1,109.6 million, a basic EPS loss of US$10.15 and trailing twelve month revenue of US$4.3 billion alongside a basic EPS loss of US$10.12. Over the past six reported quarters, revenue has moved in a tight band between US$1,043.3 million and US$1,138.3 million, while EPS has swung from a small profit of US$0.09 in Q3 2025 to quarterly losses such as US$0.30 in Q4 2024 and US$10.15 in Q4...

Collegium Pharmaceutical (COLL) has wrapped up FY 2025 with fourth quarter revenue of US$205.4 million and basic EPS of US$0.54, capping a year in which trailing 12 month revenue reached US$780.6 million and EPS came in at US$1.98. Over the last six reported quarters, revenue has moved from US$159.3 million in Q3 2024 to US$205.4 million in Q4 2025, while quarterly EPS has ranged from US$0.29 to US$1.00. This gives investors a clear view of how profitability tracks alongside top line...

Montrose Environmental Group (MEG) closed out FY 2025 with Q4 revenue of US$193.3 million and a basic EPS loss of US$0.23, compared with Q4 FY 2024 revenue of US$189.1 million and a basic EPS loss of US$0.90, while on a trailing 12 month basis revenue stood at US$830.5 million and basic EPS at a loss of US$0.14. Over the past few quarters, revenue has moved from US$178.7 million in Q3 FY 2024 to US$234.5 million in Q2 FY 2025, alongside EPS that ranged from a loss of US$0.64 in Q1 FY 2025 to...

Krispy Kreme (DNUT) has wrapped up FY 2025 with Q4 revenue of US$392.4 million and a basic EPS loss of US$0.16. Trailing twelve month figures show revenue of about US$1.5 billion and a basic EPS loss of US$3.02. The company’s quarterly revenue moved from US$404.0 million in Q4 FY 2024 to US$392.4 million in Q4 FY 2025, with EPS shifting from a loss of US$0.13 to a loss of US$0.16. Over the same period, TTM EPS moved from a small profit of US$0.02 in late FY 2024 to the current loss. Together,...

ATCO (TSX:ACO.X) FY 2025 Earnings Snapshot ATCO (TSX:ACO.X) closed out FY 2025 with Q4 revenue of CA$1.4 billion and a basic EPS loss of CA$1.29, as net income excluding extra items came in at a loss of CA$143 million. Over the past two quarters, the company has seen quarterly revenue move from CA$1.2 billion in Q3 2025, with basic EPS of CA$0.76, to CA$1.4 billion in Q4 2025 alongside the swing into a quarterly loss. With trailing twelve month EPS at CA$1.34 and net margins sitting well...

Hamilton Beach Brands Holding (HBB) has rounded out FY 2025 with fourth quarter revenue of US$212.9 million and basic EPS of US$1.38, anchored by net income of US$18.5 million. Over the past few quarters, revenue has moved from US$156.7 million in Q3 2024 to a range of US$127.8 million to US$213.5 million through FY 2025, while quarterly EPS has run between US$0.12 and US$1.76 across this period. This gives investors a clearer view of how earnings power has tracked alongside sales. With...

Why Western Digital Stock Is On Investors’ Radar Western Digital (WDC) has drawn attention after a strong past 3 months, with the share price up about 73%, prompting investors to reassess how its current fundamentals align with that move. See our latest analysis for Western Digital. While the share price has eased slightly in the last week, Western Digital’s recent 11.7% 1 month share price return and very large 1 year total shareholder return suggest momentum has been strong over both...

Tecnoglass (TGLS) closed out FY 2025 with fourth quarter revenue of US$245.3 million and basic EPS of US$0.57, alongside trailing 12 month EPS of US$3.42 on revenue of US$983.6 million. The company has seen quarterly revenue move from US$239.6 million and EPS of US$1.00 in Q4 2024 to US$245.3 million and EPS of US$0.57 in Q4 2025. Trailing 12 month revenue has shifted from US$890.2 million and EPS of US$3.43 to US$983.6 million and EPS of US$3.42 over the same period, giving investors a clear...

Viridian Therapeutics (VRDN) FY 2025 earnings snapshot Viridian Therapeutics (VRDN) closed FY 2025 with Q4 revenue of about US$0.1 million, Basic EPS of a US$1.71 loss, and a net income loss of roughly US$161.7 million, with the trailing twelve months showing a Basic EPS loss of US$4.04 on revenue of about US$70.8 million and a net income loss of roughly US$342.6 million. Over recent quarters, the company has seen quarterly revenue move between about US$0.1 million and US$70.6 million, while...

kneat.com (TSX:KSI) has wrapped up FY 2025 with fourth quarter revenue of CA$17.0 million and a basic EPS loss of CA$0.04, alongside a net loss of CA$3.6 million. Over recent reporting periods, the company has seen revenue move from CA$13.7 million in Q4 2024 to CA$17.0 million in Q4 2025, while quarterly basic EPS has ranged between a profit of CA$0.02 in Q1 2025 and a loss of CA$0.04 in Q4 2025. This sets up a story where top line growth is occurring alongside margins that remain under...

GeoPark (NYSE:GPRK) has wrapped up FY 2025 with Q4 revenue of US$110.3 million and basic EPS of US$0.60, while trailing 12 month figures show revenue of US$492.5 million and EPS of US$0.96. Over the past few quarters, revenue has ranged from US$110.3 million to US$137.3 million, with quarterly EPS moving between a loss of US$0.20 and a profit of US$0.60. This places margins and consistency front of mind for investors as they assess the past year. See our full analysis for GeoPark. With the...

SBI Holdings stock: recent returns and business mix SBI Holdings (TSE:8473) has drawn fresh attention after a mixed run in recent months, with a 1 day gain of 4.3% set against a negative month return and modest past 3 months performance. Over longer periods, the stock shows a 55.7% 1 year total return and 3 year and 5 year total returns of about 2.6x and 2.8x respectively. These figures sit beside a year to date decline of 3.9%. The group reported revenue of ¥1.92b and net income of ¥410.10m,...

CrossAmerica Partners (CAPL) has wrapped up FY 2025 with fourth quarter revenue of US$1.1b and basic EPS of US$0.32, alongside trailing 12 month EPS of US$1.10 on revenue of US$3.7b that includes a large one off gain of US$44.2m. Over recent quarters, revenue has moved from US$861.6m in Q4 2024 to US$1.1b in Q4 2025 while quarterly EPS has ranged from a loss of US$0.20 in Q1 2025 to a high of US$0.64 in Q2 2025. This sets up a picture where higher trailing earnings sit next to slim net...

Carlyle Group (CG) has laid out new three year financial targets and earnings objectives at its 2026 Shareholder Update, pairing that guidance with a fresh US$2b share repurchase authorization. See our latest analysis for Carlyle Group. Carlyle’s latest update lands after a choppy few months for the share price, with a 5.64% 1 day share price return and a 2.79% 7 day share price return, but a 9.71% 30 day share price decline that contrasts with a 15.16% 1 year total shareholder return and an...

Consolidated Edison (NYSE:ED) announced a US$38b capital investment plan over the next five years. The plan focuses on grid reliability and clean energy projects tied to electric vehicles and building electrification. The spending roadmap responds to evolving policy and demand trends in New York's energy market. Consolidated Edison, the regulated utility serving New York City and surrounding areas, is leaning into long term shifts in how homes, businesses and transport use electricity. The...

Heron Therapeutics (HRTX) just closed out FY 2025 with Q4 revenue of US$40.6 million and a basic EPS loss of US$0.02, alongside a trailing 12 month revenue base of US$154.9 million and a TTM basic EPS loss of US$0.12. Over recent quarters the company has seen revenue move between US$32.8 million and US$40.8 million, while quarterly basic EPS has ranged from a profit of US$0.02 to a loss of US$0.10. This gives investors a clearer view of how top line scale and per share results have been...